Filing Details

Accession Number:
0001567619-21-020585
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-11-16 17:23:06
Reporting Period:
2021-11-16
Accepted Time:
2021-11-16 17:23:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1505497 Biorestorative Therapies Inc. BRTX Services-Misc Health & Allied Services, Nec (8090) 911835664
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1527241 Francisco Silva 40 Marcus Drive
Melville NY 11747
Vp Of Research And Development Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-11-16 3,826 $6.83 3,829 No 4 P Indirect IRA
Common Stock Acquisiton 2021-11-16 4,000 $6.63 7,829 No 4 P Indirect IRA
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect IRA
No 4 P Indirect IRA
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 148,848 Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option $3,000.00 2022-02-09 1 1 Direct
Common Stock Stock Option $3,000.00 2022-05-02 1 1 Direct
Common Stock Stock Option $3,000.00 2022-12-07 1 1 Direct
Common Stock Stock Option $3,000.00 2023-10-04 1 1 Direct
Common Stock Stock Option $3,000.00 2024-02-18 3 3 Direct
Common Stock Stock Option $3,000.00 2014-03-12 2024-03-11 1 1 Direct
Common Stock Stock Option $3,000.00 2014-04-14 2022-05-02 1 1 Direct
Common Stock Stock Option $3,000.00 2024-10-23 9 9 Direct
Common Stock Stock Option $3,000.00 2025-09-04 6 6 Direct
Common Stock Stock Option $3,000.00 2026-06-10 15 15 Direct
Common Stock Stock Option $3,000.00 2027-07-12 20 20 Direct
Common Stock Stock Option $3,000.00 2028-10-29 25 25 Direct
Common Stock Stock Option $13.50 2031-03-18 293,479 293,479 Direct
Common Stock Stock Option $13.50 2031-11-04 42,059 42,059 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2022-02-09 1 1 Direct
2022-05-02 1 1 Direct
2022-12-07 1 1 Direct
2023-10-04 1 1 Direct
2024-02-18 3 3 Direct
2024-03-11 1 1 Direct
2022-05-02 1 1 Direct
2024-10-23 9 9 Direct
2025-09-04 6 6 Direct
2026-06-10 15 15 Direct
2027-07-12 20 20 Direct
2028-10-29 25 25 Direct
2031-03-18 293,479 293,479 Direct
2031-11-04 42,059 42,059 Direct
Footnotes
  1. Includes 146,740 shares received pursuant to an unvested restricted stock unit grant. Such shares vest to the extent of 48,914 shares on March 18, 2022 and 48,913 shares on each of March 18, 2023 and March 18, 2024.
  2. The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $6.73 to $6.88, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.
  3. The option is currently exercisable.
  4. The option is exercisable subject to the satisfaction of certain conditions.
  5. The option vests and becomes exercisable to the extent of 146,740 shares on March 18, 2021, 36,684 shares on November 4, 2021 and the remaining 110,055 shares in six nearly equal quarterly installments beginning December 18, 2021 and continuing every three months thereafter until fully vested.
  6. The option vests and becomes exercisable to the extent of 21,030 shares on November 4, 2021 with the remaining 21,029 shares vesting quarterly in eight nearly equal installments beginning on November 4, 2022.